MetaCap

Climb Bio Statistics

NASDAQ: CLYMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.19-0.09 (-0.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Climb Bio by the numbers

Climb Bio has a market capitalization of $539.8 million based on 58.74M shares outstanding. With trailing EPS of $-0.81, Climb Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.6% below its 50-day average and 14.8% below its 200-day average.

Average daily trading volume is 1.38M shares, or about $12.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CLYM valuation vs. peer median

CLYM compared with the median of 8 peer companies
MetricCLYMPeer medianDifference
Market cap$539.80M$544.88M-1%
Avg. volume1.38M1.28M+7%

Peer median across 8 companies: ACRS, AVBP, CBIO, ANL, BCAX, GERN, ZVRA, ALMS.

Valuation

Price and trading

Previous close
9.28
Open
8.94
Day range
8.90 – 9.40
52-week range
1.64 – 18.33
52-week change
+440.59%
Beta
—
Volume
770.17K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
539.80M
Forward Pe
-9.22
Eps
-0.81
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
18.33
Week52 Low
1.64
Avg Volume
1.38M
Shares Outstanding
58.74M
Ma50
11.01
Ma200
10.79
Earnings Date
Nov 5, 2026
Pct From52w High
-49.86%
Pct From52w Low
462.08%

Related